Mutlu Deniz, Simsek Bahadir, Rempakos Athanasios, Alexandrou Michaella, Al-Ogaili Ahmed, Azzalini Lorenzo, Rinfret Stephane, Khatri Jaikirshan J, Alaswad Khaldoon, Jaffer Farouc A, Jaber Wissam, Basir Mir B, Goktekin Omer, Gorgulu Sevket, Krestyaninov Oleg, Khelimskii Dmitrii, Davies Rhian, Frizzel Jarrod, Choi James W, Chandwaney Raj H, Potluri Srinivasa, Poommipanit Paul, Uretsky Barry, Ybarra Luiz F, Murad Bilal, Rangan Bavana V, Mastrodemos Olga C, Sandoval Yader, Burke M Nicholas, Brilakis Emmanouil S
Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN, USA.
Yale University, School of Medicine, Department of Internal Medicine, New Haven, CT, USA.
Cardiovasc Revasc Med. 2025 Jul;76:66-72. doi: 10.1016/j.carrev.2024.10.007. Epub 2024 Oct 28.
The J-CTO investigators recently developed angiographic difficulty scores for each of the three major coronary arteries in patients undergoing first-attempt chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in de novo occlusions.
We examined the performance of the individual J-CTO scores in a large multicenter registry.
The CTO lesion location was as follows: right coronary artery (RCA) 3,805 (54%), left anterior descending artery (LAD) 2,303 (33%), and left circumflex (LCX) 935 (13%). Patients in the PROGRESS-CTO registry were younger, more likely to be female, and had higher J-CTO scores compared with the J-CTO registry. Increasing difficulty scores were associated with lower technical success in the PROGRESS-CTO registry (score 0: 94.4 % - score ≥3: 82.6% for the RCA difficulty score; score 0: 96.4% - score ≥3: 86.1 for the LAD difficulty score; and score 0: 95.4% - score ≥3: 81.2% for the LCX difficulty score). The C-statistic of the coronary artery specific J-CTO scores in the PROGRESS-CTO registry were: LAD 0.69 (95% confidence intervals [CI], 0.64-0.73), LCX 0.63 (95% CI, 0.57-0.69), and RCA 0.61 (95-% CI, 0.58-0.64) with good calibration (Hosmer-Lemeshow p-value >0.05 for all). The AUC of the classic J-CTO score for LAD lesions was similar with the LAD J-CTO score (p-for-difference = 0.26), but worse for LCX (p-for-difference = 0.04) and RCA lesions (p-for-difference = 0.04).
In the PROGRESS-CTO registry, the coronary artery specific J-CTO scores did not improve prediction of the technical success of CTO-PCI compared with the classic J-CTO score.
J-CTO研究人员最近针对首次尝试对初发闭塞病变进行慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的患者,制定了针对三条主要冠状动脉各自的血管造影难度评分。
我们在一个大型多中心注册研究中检验了各个J-CTO评分的性能。
CTO病变位置如下:右冠状动脉(RCA)3805例(54%),左前降支(LAD)2303例(33%),左旋支(LCX)935例(13%)。与J-CTO注册研究相比,PROGRESS-CTO注册研究中的患者更年轻,女性比例更高,J-CTO评分也更高。在PROGRESS-CTO注册研究中,难度评分增加与技术成功率降低相关(RCA难度评分:评分0:94.4% - 评分≥3:82.6%;LAD难度评分:评分0:96.4% - 评分≥3:86.1%;LCX难度评分:评分0:95.4% - 评分≥3:81.2%)。PROGRESS-CTO注册研究中冠状动脉特异性J-CTO评分的C统计量分别为:LAD 0.69(95%置信区间[CI],0.64 - 0.73),LCX 0.63(95%CI,0.57 - 0.69),RCA 0.61(95%CI,0.58 - 0.64),校准良好(所有Hosmer-Lemeshow p值>0.05)。经典J-CTO评分对LAD病变面积的曲线下面积(AUC)与LAD的J-CTO评分相似(差异p值 = 0.26),但对LCX病变(差异p值 = 0.04)和RCA病变(差异p值 = 0.04)而言较差。
在PROGRESS-CTO注册研究中,与经典J-CTO评分相比,冠状动脉特异性J-CTO评分并未改善对CTO-PCI技术成功率的预测。